HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denise Williams Selected Research

Epoetin Alfa (Epogen)

12/2007An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy.
9/2007An extended dosing regimen of epoetin alfa 60,000 units every 2 weeks in anemic patients with cancer receiving chemotherapy.
3/2007A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
10/2006An open-label pilot study to evaluate a flexible dosing regimen of epoetin alfa for the treatment of chemotherapy-induced anemia: 60,000 units weekly followed by 60,000 units every 2 weeks.
8/2006Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.
7/2006Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia.
3/2006Weekly epoetin alfa treatment of anemia in patients with cancer not undergoing therapy.
10/2005A pilot study to evaluate the safety and clinical outcomes of once-weekly epoetin alfa 80,000 u in anemic patients with cancer receiving chemotherapy.
9/2005Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.
6/2005Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denise Williams Research Topics

Disease

13Neoplasms (Cancer)
07/2009 - 06/2005
8Anemia
12/2007 - 06/2005
2Disease Progression
01/2022 - 01/2013
2Optic Atrophy
01/2022 - 01/2017
2Wolfram Syndrome (Syndrome, Wolfram)
01/2022 - 01/2017
2Brain Diseases (Brain Disorder)
01/2021 - 01/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2016 - 02/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2013 - 06/2011
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2011 - 02/2009
1Vision Disorders (Hemeralopia)
01/2022
1Abnormal Karyotype
01/2020
1Microphthalmos
01/2020
1Aneuploidy (Aneuploid)
12/2019
1Trisomy (Trisomies)
12/2019
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2019
1Facioscapulohumeral Muscular Dystrophy
02/2017
1Megaloblastic Anemia
01/2017
1Hypokinesia (Bradykinesia)
11/2015
1Muscular Diseases (Myopathy)
11/2015
1Arthrogryposis
11/2015
1Neuromuscular Diseases (Neuromuscular Disease)
11/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2015
1Lymphoma (Lymphomas)
09/2015
1Burkitt Lymphoma (Burkitt's Lymphoma)
09/2015
1Hodgkin Disease (Hodgkin's Disease)
05/2014
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2013
1Pleural Effusion (Pleural Effusions)
01/2013
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2013
1Mycosis Fungoides
01/2013
1Infections
07/2011
1Stomatitis
07/2011
1Medulloblastoma
07/2009
1Wilms Tumor (Wilm's Tumor)
11/2008
1Growth Disorders
11/2008
1Infertility (Sterility)
02/2008
1Sarcoma (Soft Tissue Sarcoma)
02/2008
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
02/2008
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2007
1Brain Neoplasms (Brain Tumor)
08/2006
1Mood Disorders (Mood Disorder)
12/2005
1Schizophrenia (Dementia Praecox)
12/2005
1Adenocarcinoma
08/2005
1Fatigue
06/2005
1Breast Neoplasms (Breast Cancer)
06/2005

Drug/Important Bio-Agent (IBA)

10Epoetin Alfa (Epogen)FDA Link
12/2007 - 06/2005
9Hemoglobins (Hemoglobin)IBA
12/2007 - 06/2005
3Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2005
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 11/2008
2Methotrexate (Mexate)FDA LinkGeneric
09/2015 - 02/2009
2PanobinostatIBA
05/2014 - 01/2013
1fibroblast growth factor 13IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1N 30IBA
01/2020
1Cell-Free Nucleic AcidsIBA
12/2019
1dichlorobis(azomycin)platinum IIIBA
12/2019
1Inosine TriphosphataseIBA
01/2019
1Insulin (Novolin)FDA Link
01/2017
1Thiamine (Aneurin)FDA Link
01/2017
1TungstenIBA
01/2017
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2015
1Cytarabine (Cytosar-U)FDA LinkGeneric
09/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2015
1Alkylating AgentsIBA
09/2015
1AnthracyclinesIBA
09/2015
1Rituximab (Mabthera)FDA Link
09/2015
1Chemokine CCL17IBA
05/2014
1ChemokinesIBA
05/2014
1CytokinesIBA
05/2014
1Bexarotene (LGD1069)FDA Link
01/2013
1Tyrosine Kinase InhibitorsIBA
01/2013
1Transaminases (Aminotransferases)IBA
07/2011
1nilotinibFDA Link
06/2011
1Dasatinib (BMS 354825)FDA Link
06/2011
1Cisplatin (Platino)FDA LinkGeneric
07/2009
1Leucovorin (Folinic Acid)FDA Link
02/2009
1IfosfamideFDA LinkGeneric
02/2008
1Sunitinib (Sutent)FDA Link
02/2008
1Imatinib Mesylate (Gleevec)FDA Link
02/2008
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2008
1Inosine Diphosphate (IDP)IBA
12/2007
1NicotineFDA Link
12/2005
1Darbepoetin alfa (Aranesp)FDA Link
09/2005
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
08/2005
1Mitogen-Activated Protein Kinase 3IBA
08/2005
1lipid-associated sialic acid (LASA)IBA
06/2005

Therapy/Procedure

15Drug Therapy (Chemotherapy)
09/2015 - 06/2005
9Therapeutics
02/2017 - 06/2005
1PVDA protocol
07/2011
1Spinal Injections
02/2009
1Treatment Delay
03/2007
1Radiotherapy
03/2006
1Subcutaneous Injections
03/2006
1Nicotine Replacement Therapy
12/2005
1Erythrocyte Transfusion
10/2005
1Drug Tapering
10/2005
1Adjuvant Chemotherapy
06/2005